Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,518.61 16.96 0.10%
S&P 500 1,881.23 5.84 0.31%
NASDAQ 4,151.34 24.38 0.59%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

STAAR Surgical Announces Third Quarter 2013 Results Release Date, Conference Call And Webcast



 STAAR Surgical Announces Third Quarter 2013 Results Release Date, Conference
                               Call And Webcast

PR Newswire

MONROVIA, Calif., Oct. 17, 2013

MONROVIA, Calif., Oct. 17, 2013 /PRNewswire/ -- STAAR Surgical Company
(NASDAQ: STAA) today announced that it will release its financial results for
the third quarter ended September 27, 2013 on Wednesday, October 30, 2013
after the market close.

STAAR will host a conference call and webcast on Wednesday, October 30 at 4:30
p.m. Eastern / 1:30 p.m. Pacific to discuss these results and recent corporate
developments. The dial-in number for the conference call is 866-202-0886 for
domestic participants and 617-213-8841 for international participants, both
using the passcode 83227474.  The Company will also be using slides to
illustrate its third quarter results and operational progress.  The slides and
live webcast of the call can be accessed from the investor relations section
of the STAAR website at www.staar.com.   

A taped replay of the conference call will also be available beginning
approximately one hour after the call's conclusion and will be available for
seven days.  This replay can be accessed by dialing 888-286-8010 for domestic
callers and 617-801-6888 for international callers, both using passcode
25998756.  An archived webcast will also be available at www.staar.com.

About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25
years, designs, develops, manufactures and markets implantable lenses for the
eye and delivery systems therefor. All of these lenses are foldable, which
permits the surgeon to insert them through a small incision. STAAR's lens used
in refractive surgery as an alternative to LASIK is called an Implantable
Collamer® Lens or "ICL." A lens used to replace the natural lens after
cataract surgery is called an intraocular lens or "IOL." Over 375,000 Visian
ICLs have been implanted to date; to learn more about the ICL go to:
www.visianinfo.com. STAAR has approximately 300 full time employees and
markets lenses in over 60 countries. Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA;
and Monrovia, CA. For more information, please visit the Company's website at
www.staar.com. 

Collamer® is the registered trademark for STAAR's proprietary biocompatible
collagen copolymer lens material. 

CONTACT: Investors                 Media
         EVC Group                 EVC Group
         Doug Sherk, 415-652-9100  Janine McCargo
         Leigh Salvo, 415-568-9348 646-688-0425

SOURCE STAAR Surgical Company

Website: http://www.staar.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement